Is OrganiGram Stock a Buy After British American Tobacco’s Investment?

1 min read

OrganiGram (NASDAQ: OGI) leaped into the spotlight recently on the news that British American Tobacco (NYSE: BTI) bought a big stake in the Canadian marijuana company. 

In this video captured from Motley Fool Live on March 12, veteran Fool contributor Eric Volkman and healthcare and cannabis bureau chief Corinne Cardina discuss whether OrganiGram is a now a buy in the wake of that deal.

 

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

5 Pot Stocks Poised to Strike It Rich From Recent Legalization Moves

Next Story

Chamath Palihapitiya Has Invested in 14 Different SPACs and PIPEs — Which Are the Best Buys Now?

Latest from Blog